Touchstone Sands Capital Select Growth Fund Institutional Class
CISGX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 303 Broadway Cincinnati OH United States of America 45202
- IPO Date
- Sep 2, 2020
- CIK
- 0001174490
- Website
- westernsouthern.com
- Similar Companies
- Business
- Touchstone Sands Capital Select Growth Fund Institutional Class (CISGX) is a mutual fund that seeks long-term capital appreciation by investing primarily in common stocks of U.S. and non-U.S. companies with strong growth potential, emphasizing high-quality businesses with sustainable competitive advantages. The fund offers institutional-class shares characterized by a minimum investment requirement, lower expense ratios compared to retail classes, and daily liquidity; it employs a growth-oriented strategy focused on sectors such as technology, healthcare, and consumer discretionary, with portfolio holdings typically including large-cap leaders like those in semiconductors, software, and biotechnology. Managed through a partnership between Touchstone Investments and Sands Capital Management, the fund operates globally but with a core focus on U.S. equities, serving institutional investors including endowments, foundations, and high-net-worth advisors. The fund traces its roots to Touchstone Investments, established in 1982 and headquartered in Cincinnati, Ohio, with Sands Capital Management, founded in 2002 and based in Arlington, Virginia, providing sub-advisory expertise in growth equity selection. In a significant strategic development in 2024, the fund rebranded from Touchstone Sands Capital Growth Opportunities Fund to its current name, reflecting refined investment objectives and enhanced alignment with Sands Capital's proprietary research-driven process; this change coincided with portfolio optimizations amid market volatility. No major acquisitions, funding rounds, or new product launches have been reported in the last 1-2 years, though the fund continues to adapt holdings to capitalize on megatrends like artificial intelligence and innovative healthcare solutions.